During the past years, a number of T cell antigens defined by conventional serology and monoclonal antibodies have become the basis for the distinction of T cell subsets, especially in the human, murine, and rat systems (reviewed in reference 1). Some of these markers have been directly correlated with T cell functions, either because they are only expressed on a given functional subset or because antibodies to them block or stimulate certain T cell reactions. A well studied example is the murine Lyt-2 (human OKT8/Leu-2) antigen. Originally thought to be a marker for cytotoxic (and suppressor) T cells (2), more recent data suggest an association of this antigen with T cell recognition of class I major histocompatibility complex (MHC) 1 antigens rather than with cytolytic function (3). Thus, Class I-specific helper T cells were found to be Lyt-2 + as well (4), and conversely, class II specific cytolytic T lymphocytes (CTL) with little or no Lyt-2 antigen were described (5). In the human, an analogous antigen is known to be associated with the recognition of class II MHC antigens (OKT4/Leu-3) (6, 7), and its likely murine counterpart (L3T4) has been described recently (8). The strongest evidence for an involvement of the molecules bearing these antigens in the recognition of MHC restriction elements is the capacity of antiLyt-2 (3) and anti-L3T4 (8) antibodies (and their counterparts in the human system [9] ) to block the activities of cytotoxic and helper T cells that recognize class I and class II antigens, respectively. Accordingly, it has been proposed that the T cell structures defined by these antibodies interact with monomorphic determinants on MHC molecules, thereby providing an MHC class-specific recognition step in addition to the T cell receptors' interaction with its target antigen (3).
can be blocked with monoclonal anti-Lyt-2 has been interpreted as a key result supporting this hypothesis (14) . On the other hand, H-2-negative cells can serve as targets in LDCC (15) and as accessory cells in polyclonal T cell activation. 2 In the present report, the hypothesis that anti-Lyt-2 blocks at the level of MHC class recognition was tested by examining its capacity to inhibit LDCC of H-2-positive and H-2-negative target cells.
Materials and Methods
Mice. Balb.K (H-2 k, Lyt-2.2), CBA/J (H-2 k, Lyt-2.1), and BALB/c (H-2 d, Lyt-2.2) mice were bred in our colony and used at 2-6 months of age.
Generation ofCytotoxic Effector Cells. Spleen cells were cultured in RPMI 1640 supplemented as given in reference 16. They were either stimulated for 3 d with concanavalin A (Con A) (2 ~g/ml) at 2 × 106/ml in 2-ml cultures seeded into 24-well tissue culture plates (Costar, Data Packaging, Cambridge, MA), or for 5 d with irradiated (2,000 rads from a 6°Co source) allogeneic spleen cells as described (16) . Con A-induced CTL were incubated with 50 mM a-methyl-mannoside for 15 min, followed by two washes, before the CTL assay.
Target Cells. The C58/J (H-2 k, Lyt-2.1) thymoma R 1.1 and the t32-microglobulin (and therefore H-2 k) negative variant R1E/TL8x. 1 (for short, R1.E), which were derived and characterized by Hyman and Stallings (17) , were kindly provided by Dr. K. FischerLindahi (Basel Institute for Immunology). They were labeled with 100 ~Ci S~Cr-Na~CrO4 in 0.5 ml BSS/BSA in the presence or in the absence of 5 #g Con A, followed by two washes.
Antibodies. The hybridoma 19/1782c producing anti-Lyt-2.2 antibody of the IgG2a subclass was kindly provided by Dr. G. Hfimmerling (DKFZ, Heidelberg, FRG). IgG was prepared from ascitic fluid by ammonium sulfate precipitation and fractionation on an Affigel blue column (Biorad Laboratories GmbH, Mfincben, FRG). As judged by protein staining of SDS-PAGE, the recovered material contained almost exclusively IgG. Anti LFA-I (18), the kind gift of Dr. M. Pierres (Centre D'Immunologie de Marseille-Lfiminy), was used in the form of culture supernatant (hybridoma clone H 35-89.9 rat ~'2b). (16) . The cytotoxic effector cells were preincubated with the monoclonal antibodies in a total volume of 0.5 ml supplemented (16) RPMI for 30 min at 4°C in 120 mm × 7.5 mm polystyrene tubes. 4 × 104 target cells were added in another 0.5 ml of medium, and the mixture was incubated for 4 h at 37°C in an atmosphere containing 5% CO2 in air. After mixing and centrifugation at 2,000 rpm for 5 min, 0.5-ml samples of the supernatants were counted. Specific lysis was calculated according to the formula: experimental release -spontaneous release % specific lysis = 100 × detergent release -spontaneous release
CTL Assay

Results
Btockb~g of Specie and Lecti~-d@endent Lympholysis Mediated by Atloreactive CTL
with Monoclo~ml Anti-Lyt-2.2 Antibody. Fig. 1 shows an experiment in which BALB/c anti-Baib.K (H-2 d anti-H-2 k) CTL were tested against the C58/J thymoma R1.1 (H-2 k) and the ~2-microglobulin defective and therefore H-2 k negative variant, R1.E. As expected, only the H-2k-positive target cells were lysed ( Fig. 1 A) . However, pretreatment with Con A rendered R1.E cells susceptible to lysis as well ( Fig. 1 C) . This is in agreement with results of Bevan and Hyman (15), who first described LDCC of H-2-negative cells. Inclusion of 10 tag/ml purified anti-Lyt-2.2 antibody markedly reduced both the antigen-specific ( Spontaneous release varied from 14.4 to 25.8%.
1A) lysis of H-2 k positive and LDCC of H-2-negative target cells (Fig. 1 C) . Titration of the antibody at a constant effector/target ratio (Fig. 1 , B and D) indicated that similar antibody concentrations were required for inhibition in both systems.
Blocking of LDCC Mediated by Polyclonally Induced CTL with Anti-Lyt-2.2 and Anti-LFA-I.
In the experiment shown in Fig. 2 , Con A-pulsed R 1.1 (Fig. 2, A and B) and R 1.E (Fig. 2 , C and D) cells were used as targets for polyclonally (Con A-) induced CTL. LDCC of the H-2-negative target was less than that of the H-2-positive parent line (note the different scale), but was significant and reproducible. As can be seen, monoclonal anti-Lyt-2.2 inhibited lysis of both targets. In addition, culture supernatants from a hybridoma producing anti-LFA-1 antibody were inhibitory in both systems. Unlike Lyt-2, LFA-1 expression is not correlated with class I or class II MHC recognition (8) . Again, similar titration curves were obtained for these antibodies in the blocking of LDCC of H-2-positive and H-2-negative target cells. While the blocking of LDCC of both types of target cells with anti-Lyt-2.2 and anti-LFA-1 was a consistent finding, the relative efficiency with which the two antibodies inhibited was variable from experiment to experiment. The allele specificity of blocking with monoclonal anti-Lyt-2.2 antibody is shown in Table I . Lysis of Con A-pulsed R 1.1 and R I.E target cells by Balb.K (Lyt-2.2) but not by CBA (Lyt-2.1) Con A-activated CTL was blocked. In contrast, anti-LFA-1, a rat antibody reactive with LFA-1 on the cells of all mouse strains, was inhibitory for effector ceils from both strains.
Discussion The experiments presented here show that monoclonal anti-Lyt-2 antibodies can block LDCC of H-2-negative target cells. The minimal conclusion to be drawn is that in LDCC, blocking with anti-Lyt-2 antibodies cannot be taken as evidence for the recognition of class I H-2 antigens in LDCC. Unless two distinct mechanisms by which anti-Lyt-2 blocks T cell-mediated cytotoxicity are to be postulated, this conclusion can be extrapolated to antigen-specific T cell killing as well.
Basically, two functions have been suggested for the Lyt-2 bearing T-cell surface molecule: strengthening of adhesion between CTL and target cell (12, 20) , and recognition of class I MHC antigens (3). Both proposals take into account that inhibition of cytolysis by anti-Lyt-2 antibodies operates at the level of CTL-target cell conjugate formation (21) . The finding that antibodies to LFA-1 (18) interfere with the same step in T cell-mediated target cell destruction (20) seems to put Lyt-2 and LFA-1 into the same category. Unlike blocking by anti-LFA-1, however, which affects T cells recognizing H-2 class I and class II antigens, sensitivity to inhibition by anti-Lyt-2 is considered a property of only class I-specific T cells (3) . The idea that the Lyt-2-bearing molecule is itself the T cell receptor had to be discarded with the discovery ofcodominant expression of both Lyt-2 alleles on the same cell (22) . Instead, it has been proposed that Lyt-2 is part of the T cell receptor complex, where it functions as a MHC classspecific receptor by interacting with monomorphic determinants on class I molecules (3). Exceptions have, however, been found to the rule that class I MHC recognition is associated with Lyt-2 expression (23, 24) , and some Lyt-2 + CTL are resistant to blocking with anti-Lyt-2 antibodies (25) . In view of these findings, the involvement of the Lyt-2 antigen in the adhesion of class I-specific T cells to their targets has more cautiously been interpreted as a "stabilizing" effect that is required only in low affinity interactions of the T cell receptor with class I antigens (25) .
According to the data presented here, sensitivity to blocking with anti-Lyt-2 can not be regarded as evidence for the recognition of class I MHC antigens. On the other hand, the predominant expression of Lyt-2 on class I-specific T cells remains suggestive of its involvement in the T cell receptor complex. Thus, it could be envisaged that even in LDCC of H-2-negative target cells, participation of the T cell receptor complex is required. If the Lyt-2 antigen is part of that complex, blocking of both LDCC and antigen-specific killing may proceed by a mechanism distinct from interfering with the postulated interaction of the Lyt-2-bearing structure with monomorphic class I determinants.
A result possibly analogous to the one reported here about anti-Lyt-2 was recently published for the monoclonal antibody against L3T4, the presumptive murine analogue to the human T4 antigen, which is found associated with class II recognition (8) . This antibody was selected in a screening assay in which LDCC of P815 (i. e. class II negative!) target cells by a T cell clone of unknown (but presumably class II restricted) specificity was blocked.
Finally, the blocking of LDCC of H-2-negative target cells with anti-Lyt-2 indicates that CTL, and not natural killer (NK) cells, are the effector cells in this system. This supports the notion that T cell reactivities mediated by lectins need not involve MHC antigens on target (or "accessory") cells (15) . 2
Summary
The hypothesis that blocking of cytotoxic T lymphocyte (CTL)-mediated cytolysis with anti-Lyt-2 antibodies acts at the level of inhibiting the interaction of the Lyt-2-bearing structure with H-2 class I molecules was tested. In agreement with the findings of others, purified anti-Lyt-2.2 inhibited both antigenspecific lysis and lectin-dependent cellular cytotoxicity (LDCC). LDCC of H-2-positive and H-2-negative target cells was similarly inhibited by this antibody. As expected, this effect was specific for CTL expressing the Lyt-2.2 allele, in contrast to blocking with a rat monoclonal antibody to the murine LFA-1 antigen. The implications of this finding for the function of the Lyt-2 antigen in CTLtarget cell interaction are discussed.
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